Aug 7 (Reuters) - Black Diamond Therapeutics Inc BDTX.O:
BLACK DIAMOND THERAPEUTICS INC - Q2 EPS $-0.19
BLACK DIAMOND THERAPEUTICS INC - HAS $142.8 MILLION CASH AS OF JUNE 30 TO FUND OPERATIONS INTO Q4 2027 - SEC FILING
Source text: [ID:n0001701541-25-000029]